Handelsbanken Fonder’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Handelsbanken Fonder’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,000	Closed	-$227K	–	1584
2023 Q2	$227K	Buy	7,000 +200	+3%	+$7.3K	﹤0.01%	1465
2023 Q1	$266K	Hold	6,800	–	–	﹤0.01%	1343
2022 Q4	$359K	Buy	6,800 +600	+10%	+$29.2K	﹤0.01%	1148
2022 Q3	$279K	Hold	6,200	–	–	﹤0.01%	1286
2022 Q2	$226K	Buy	6,200 +900	+17%	+$32.7K	﹤0.01%	1458
2022 Q1	$219K	Sell	5,300 -2,900	-35%	-$102K	﹤0.01%	1612
2021 Q4	$349K	Sell	8,200 -300	-4%	-$15K	﹤0.01%	1560
2021 Q3	$468K	Hold	8,500	–	–	﹤0.01%	1398
2021 Q2	$407K	Buy	8,500 +3,000	+55%	+$153K	﹤0.01%	1519
2021 Q1	$279K	Hold	5,500	–	–	﹤0.01%	1469
2020 Q4	$346K	Buy	+5,500	New	+$341K	﹤0.01%	1345

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Handelsbanken Fonder's SILK Position: Q3 2023 in Review

Handelsbanken Fonder sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 7,000 shares — an estimated $227K sold.

Handelsbanken Fonder first reported a position in SILK in Q4 2020 and held it in 11 quarters. The position peaked at $468K in Q3 2021. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

Handelsbanken Fonder reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Handelsbanken Fonder sold 7,000 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $227K.
Handelsbanken Fonder first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Handelsbanken Fonder's Silk Road Medical, Inc. Common Stock position peaked at $468K in Q3 2021.
166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Handelsbanken Fonder's 13F filing for Q3 2023, filed 19 Oct 2023.